2-Bromo-6-nitrotoluene synthesis
- Product Name:2-Bromo-6-nitrotoluene
- CAS Number:55289-35-5
- Molecular formula:C7H6BrNO2
- Molecular Weight:216.03
603-83-8
297 suppliers
$11.00/5g
55289-35-5
295 suppliers
$13.00/1g
Yield:55289-35-5 89%
Reaction Conditions:
Stage #1:3-nitro-o-tolylamine with hydrogen bromide in water for 0.166667 h;Reflux;
Stage #2: with sodium nitrite in water at 0 - 5; for 0.5 h;
Stage #3: with copper(I) bromide in water at 20 - 70; for 1.5 h;
Steps:
Preparation of benzoxaborole 2f
2-Methyl-3-nitrobenzenamine (45.6 g, 0.3 mol) was suspended in water (200 mL) and HBr (100 mL, 40% aq.) and the mixture was heated to reflux for 10 min. Then the mixture was cooled to 0 °C and NaNO2 (20.7 g, 0.3 mol) in water (100 mL) was added dropwise at such a rate that the temperature did not exceed 5 °C. The diazonium solution was stirred for a further 30 min at 0-5 °C and then added slowly to a stirred mixture of CuBr (43.1 g, 0.3 mol) in HBr (150 mL) and water (150 mL) at room temperature. The mixture was stirred at room temperature for 30 min and then heated to 70°C for 1h. The mixture was poured onto ice and extracted with CH2Cl2 (400 mL×3), and washed with sat. NaHCO3 and brine, dried over MgSO4, filtered and concentrated. The residue was purified by column chromatography with petroleum ether as eluent to give a pale yellow solid (58 g, 89%)The mixture of 1-bromo-2-methyl-3-nitrobenzene (37.0 g, 0.17 mol), NBS (61 g, 0.34 mol) and AIBN (0.7 g, 4.2 mmol) in CCl4 (500 mL) was refluxed overnight. The mixture was filtered and the filtrate was concentrated to give a red liquid (53 g) as a crude product which was used in the next step without any purification.1-Bromo-2-(bromomethyl)-3-nitrobenzene (53 g) and NaOAc (32.8 g, 0.4 mol) in DMF (300 mL) was stirred at 70 °C overnight. The mixture was then diluted with water and extracted with ethyl acetate. The combined organic layer was washed with brine, dried over Na2SO4, filtered and concentrated. The residue was purified by column chromatography with petroleum ether/ethyl acetate = 2 0/1 eluent to give a white solid (24.0 g, 51% over two steps).To 2-bromo-6-nitrobenzyl acetate (24.5 g, 0.089 mol) in 1,4-Dioxane (500 mL) was bubbled nitrogen in the solution for 20 min. Potassium acetate (38.4 g, 0.358mol), Pd(dppf)Cl2 (3.65 g, 4.5 mmol) and bis(pinacolato)diboron (34.1 g, 0.13 mol) were added and the reaction mixture was stirred under nitrogen at 95 °C for 20 h. The reaction mixture was then cooled and was evaporated under vacuum. The residue was partitioned between EtOAc and water. The organic layer was washed with brine, dried over Na2SO4, filtered and concentrated. The residue was purified by column chromatography with petroleum ether/ethyl acetate = 20/1 as eluent to give a white solid (11.0 g, 38%). LC-MS (ESI) m/z 322 [M+1]+, (calcd MS 321.1).To a solution of 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-nitrobenzyl acetate (11.0 g, 0.034 mol) in methanol (350 mL) was added 5 N NaOH (17 mL, 0.085 mol). The reaction mixture was stirred and refluxed under nitrogen for 24h. The reaction mixture was then concentrated under vacuum and was dissolved in 200 mL of tetrahydrofuran (THF). HCl (5 N, 60 mL, 0.3 mol) was added and the reaction mixture was stirred and heated at 40 °C for 16h. The reaction mixture was cooled, diluted with EtOAc and poured into brine. The separated organic layer was washed with brine, dried over Na2SO4, filtered and concentrated. The residue was recrystallized in the mixture of ethyl acetate and petroleum ether to give a yellow solid (5.0 g, 81%). LC-MS (ESI) m/z 180 [M+1]+, (calcd MS 179.0). 1H NMR (300 MHz, DMSO-d6): δ 9.59 (s, 1H), 8.33 (d, 1H), 8.14 (d, 1H), 7.71 (t, 1H), 5.37 (s, 2H).4-Nitrobenzo[c][1,2]oxaborol-1(3H)-ol (2.7 g, 0.015 mol) in methanol (150 mL) was added Pd/C (1.0 g) and the hydrogenation was conducted at one atmosphere and room temperature overnight to provide the desired product 2f as a yellow solid (1.5 g, 66%). LC-MS (ESI) m/z 150 [M+1]+, (calcd MS 149.1). 1H NMR (300 MHz, DMSO-d6): δ 8.92 (s, 1H), 7.02 (t, 1H), 6.90 (d, 1H), 6.62 (d, 1H), 4.99(s, 2H), 4.77(s, 2H).
References:
Li, Xianfeng;Zhang, Suoming;Zhang, Yong-Kang;Liu, Yang;Ding, Charles Z.;Zhou, Yasheen;Plattner, Jacob J.;Baker, Stephen J.;Bu, Wei;Liu, Liang;Kazmierski, Wieslaw M.;Duan, Maosheng;Grimes, Richard M.;Wright, Lois L.;Smith, Gary K.;Jarvest, Richard L.;Ji, Jing-Jing;Cooper, Joel P.;Tallant, Matthew D.;Crosby, Renae M.;Creech, Katrina;Ni, Zhi-Jie;Zou, Wuxin;Wright, Jon [Bioorganic and Medicinal Chemistry Letters,2011,vol. 21,# 7,p. 2048 - 2054] Location in patent:supporting information; experimental part
95-46-5
298 suppliers
$10.00/10 g
55289-35-5
295 suppliers
$13.00/1g
606-20-2
5 suppliers
$13.00/5g
55289-35-5
295 suppliers
$13.00/1g
88-72-2
261 suppliers
$15.00/25g
60956-26-5
290 suppliers
$8.00/10g
55289-35-5
295 suppliers
$13.00/1g
95-46-5
298 suppliers
$10.00/10 g
7149-70-4
186 suppliers
$9.00/1g
7745-93-9
288 suppliers
$5.00/5g
41085-43-2
193 suppliers
$6.00/1g
55289-35-5
295 suppliers
$13.00/1g